0.4529
Nano X Imaging Ltd stock is traded at $0.4529, with a volume of 817.79K.
It is down -7.78% in the last 24 hours and down -39.91% over the past month.
Nano X Imaging Ltd is focused on driving the world's transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform. The group combines affordable imaging hardware, progressive AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. The three segments are composed of the Nanox.ARC segment, the AI and software solutions segment, and the Radiology services segment. Key revenue is generated from Radiology Services.
See More
Previous Close:
$0.4911
Open:
$0.507
24h Volume:
817.79K
Relative Volume:
1.04
Market Cap:
$35.59M
Revenue:
$13.02M
Net Income/Loss:
$-75.02M
P/E Ratio:
-0.3946
EPS:
-1.1478
Net Cash Flow:
$-47.73M
1W Performance:
-15.79%
1M Performance:
-39.91%
6M Performance:
-83.29%
1Y Performance:
-89.01%
Nano X Imaging Ltd Stock (NNOX) Company Profile
Compare NNOX vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
NNOX
Nano X Imaging Ltd
|
0.4529 | 35.59M | 13.02M | -75.02M | -47.73M | -1.1478 |
|
ABT
Abbott Laboratories
|
104.89 | 181.50B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
94.75 | 121.20B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
294.66 | 113.02B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
44.39 | 64.33B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.60 | 49.92B | 6.30B | 1.07B | 1.09B | 1.8406 |
Nano X Imaging Ltd Stock (NNOX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-26 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Jan-06-25 | Initiated | D. Boral Capital | Buy |
| Sep-08-23 | Initiated | Alliance Global Partners | Buy |
| Jan-05-23 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-19-21 | Initiated | Ladenburg Thalmann | Buy |
| Sep-15-20 | Initiated | Berenberg | Buy |
| Sep-15-20 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-15-20 | Initiated | Oppenheimer | Perform |
View All
Nano X Imaging Ltd Stock (NNOX) Latest News
Nanox AI Ltd. Enters into Distribution Agreement with Technologic s.r.l., an Affiliate of Tecnologie Avanzate, to Commercialize Nanox.AI Bone Solution in Italy - GlobeNewswire Inc.
Form 4 Nano-X Imaging Ltd.: Attias Gali Yahav (Chief Corporate Resources) For: 14 October - Investing.com Nigeria
AI division manager receives 28,283-share grant from Nano-X Imaging (NNOX), scheduled to vest through 2028. - Stock Titan
A 28,283-share award at Nano-X Imaging (NNOX) vests in four 25% installments, subject to employment. - Stock Titan
CFO Guy Nathansohn receives a 50,000-share stock grant from Nano-X Imaging (NNOX). - Stock Titan
A 28,283-unit stock grant for Nano-X Imaging (NNOX)'s legal chief vests in four equal installments. - Stock Titan
Nano-X Imaging's CMO Aharon Cohen Tamar Awarded 28,283 RSUs Under 2019 Equity Plan - Kalkine Media
An officer receives 28,283 stock units at Nano-X Imaging (NNOX), vesting in four installments. - Stock Titan
A 28,283-unit stock grant at Nano-X Imaging (NNOX) vests in four 25% installments. - Stock Titan
Thirty business days below $1 trigger a Nasdaq notice for Nano-X Imaging (Nasdaq: NNOX). - Stock Titan
Annual meetings must occur once a calendar year and within 15 months at Nano-X Imaging (NNOX). - Stock Titan
Nano-X (NASDAQ: NNOX) calls one shareholder vote critical to its financial viability - Stock Titan
Nano-X Imaging (NNOX) CEO boosts stake with 10,000-share buy - Stock Titan
Nano-X Imaging CEO Meltzer Erez Acquires 10,000 Shares at $0.69 Each (NASDAQ: NNOX) - kalkinemedia.com
Nano-X Imaging (NNOX) director buys shares in open market, but at what price? - Stock Titan
Nano-X Imaging (NASDAQ: NNOX) CEO adds to stake with open-market share buy - Stock Titan
Nano-X (NNOX) Imaging Slashes Costs As Cash Clock Keeps Ticking - Yahoo Finance
Alliance Global Partners downgrades Nano X Imaging to Neutral - scanx.trade
Nano-X Imaging (NASDAQ: NNOX) Signs Nanox.ARC Distribution Agreement for Costa Rica - Benzinga
Nanox revenue up 37% to USD 4.2M in Q2 2026 - Medical Buyer
Nanox signs distribution deal for imaging system in Costa Rica - Investing.com
Costa Rica is set to become Nanox’s third Latin American market this year - Stock Titan
Nano-X Imaging (NNOX) Q2 2026 Earnings Call Transcript - The Globe and Mail
Nano X Imaging Ltd (NNOX) (Q2 2026) Earnings Call Highlights: Revenue Surges 37% Amid Strategic ... By GuruFocus - Investing.com Canada
Nano X Imaging Ltd (NNOX) (Q2 2026) Earnings Call Highlights: Revenue Surges 37% Amid Strategic ... - Yahoo Finance
Nano X Imaging Ltd (NNOX) (Q2 2026) Earnings Call Highlights: Re - GuruFocus
Nano-X Imaging prices $8M share and warrant placement - scanx.trade
Nano X earnings missed by $0.62, revenue fell short of estimates - Investing.com India
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Nano-X Imaging Q2 2026: Revenue Hits $4.2M, Up 37% Year-Over-Year - AlphaStreet
Nanox Q2 Revenue Rises 37% as $40.7 Million Impairment Drives Wider GAAP Loss - Yahoo Finance
Nano-X Imaging Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Nano-X Imaging Releases Q2 2026 Financial Results - AlphaStreet
NNOX: Q2 revenue rose 37% year-over-year, but a $40.7M impairment drove a $55.5M net loss - TradingView
Nano-X Imaging Q2 Earnings Call Highlights - TradingView
NNOX Looks 91.2% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
NNOX: Q2 revenue rose 37% to $4.2M, but a $40.7M impairment drove a $55.5M net loss - TradingView
Earnings call transcript: Nano-X Imaging Q2 2026 revenue miss sparks sharp premarket drop - Investing.com
Earnings call transcript: Nano-X Imaging Q2 2026 revenue miss sparks sharp premarket drop - Investing.com Canada
Nano-X Imaging Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Full Transcript: Nano X Imaging Q2 2026 Earnings Call - Benzinga
Earnings call transcript: Nano-X Imaging Q2 2026 revenue miss sparks sharp premarket drop - Investing.com UK
Nano X Imaging Q2 Results: Sales up 36% YoY, EPS misses estimates - scanx.trade
Nano-X Imaging Posts Wider Q2 Loss as It Restructures Korea Operations and Launches First Imaging Network Site - tipranks.com
Q2 2026 Nano-X Imaging Ltd Earnings Call Transcript - GuruFocus
NNOX: Q2 revenue rose 37% to $4.2M, but a $40.7M impairment drove a $55.5M net loss - TradingView
Nano-X Imaging (NNOX) discloses cash shortfall and going-concern risk - Stock Titan
Nanox Q2 2026 Earnings: Health IT Lifts Revenue as Impairment Widens Loss - TradingKey
Nanox Announces Second Quarter 2026 Financial Results and Provides Business Updates - marketscreener.com
Nanox Announces Second Quarter 2026 Financial Results and Provides Business Updates - Yahoo Finance
Nano X Imaging Ltd Stock (NNOX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Nano X Imaging Ltd Stock (NNOX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Suesskind Dan S | Director |
Sep 14 '26 |
Buy |
0.76 |
60,000 |
45,300 |
110,000 |
| Meltzer Erez | Chief Executive Officer |
Sep 10 '26 |
Buy |
0.78 |
10,000 |
7,800 |
55,443 |
| Meltzer Erez | Chief Executive Officer |
Aug 10 '26 |
Buy |
1.03 |
9,443 |
9,726 |
45,443 |
| Daniel Ran | Officer |
Aug 03 '26 |
Proposed Sale |
0.98 |
5,950 |
5,831 |
0 |
| Daniel Ran | Officer |
Jul 30 '26 |
Proposed Sale |
0.88 |
1,000 |
880 |
0 |
| Kainan Noga | Director |
Jul 28 '26 |
Buy |
0.90 |
33,000 |
29,700 |
40,792 |
| Suesskind Dan S | Director |
Jul 27 '26 |
Buy |
0.93 |
50,000 |
46,500 |
50,000 |
| Meltzer Erez | Chief Executive Officer |
Jul 27 '26 |
Buy |
0.93 |
36,000 |
33,480 |
36,000 |
| Alroy Erez | Director |
Jun 10 '26 |
Sale |
1.65 |
678 |
1,119 |
6,753 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):